During research on the
ABP-051 device (in the early 2000s), it was observed that patients using this technology experienced reduced blood sugar levels and improved blood rheology. To enhance this effect, a specific sequence of neuro-like electrical impulses affecting metabolic processes was developed and tested.
Scientific work continues worldwide to expand the device's range of applications and integrate it into comprehensive treatment methods for conditions related to increased sympathetic tone.